ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
A Sprayable Nanoplatform Breaks the Vicious Cycle of Diabetic Wounds via Photoactivated Antioxidant and Drug Delivery.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Diabetic wound healing is still a challenge, because the pathological microenvironment is characterized by a vicious cycle of oxidative stress, hypoxia, infection and chronic inflammation. Herein, we report a near-infrared (NIR) light-activated cascade nanodressing incorporated into a sprayable hyaluronic acid hydrogel. Under NIR irradiation, MXene serves not only as a photothermal substrate but also generates an interfacial electronic effect that drastically enhances the multienzyme-mimicking activities of zinc hexacyanoferrate (ZnHCF), enabling efficient ROS clearance and alleviation of hypoxia. The mild photothermal effect further triggers-controlled release of deferoxamine (DFO), which cooperates with ZnHCF to chelate free iron ions, thereby suppressing ROS generation at the source. The system also exhibits synergistic photothermal-nanoknife-Zn
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.